UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine

European urology, 2014-02, Vol.65 (2), p.367-369

2014

Volltextzugriff (PDF)

Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium

Urologic oncology, 2010-07, Vol.28 (4), p.409-428

2010

Volltextzugriff (PDF)

The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets

Cancer science, 2021-09, Vol.112 (9), p.3822-3834

2021

Volltextzugriff (PDF)

Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer

Clinical cancer research, 2009-10, Vol.15 (19), p.6008-6017

2009

Volltextzugriff (PDF)

Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis

Clinical cancer research, 2012-11, Vol.18 (21), p.5865-5877

2012

Volltextzugriff (PDF)

Molecular Subtyping of Invasive Bladder Cancer: Time to Divide and Rule?

Cancer cell, 2014-02, Vol.25 (2), p.135-136

2014

Volltextzugriff (PDF)

Distinct microRNA alterations characterize high- and low-grade bladder cancer

Cancer research (Chicago, Ill.), 2009-11, Vol.69 (21), p.8472-8481

2009

Volltextzugriff (PDF)

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

Nature reviews. Cancer, 2015-01, Vol.15 (1), p.25-41

2015

Volltextzugriff (PDF)

ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer

Scientific reports, 2019-04, Vol.9 (1), p.5740-5740, Article 5740

2019

Volltextzugriff (PDF)

Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer

Cancer discovery, 2013-09, Vol.3 (9), p.1058-1071

2013

Volltextzugriff (PDF)

FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms

PloS one, 2012-06, Vol.7 (6), p.e38972

2012

Volltextzugriff (PDF)

TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p

Nature communications, 2017-10, Vol.8 (1), p.947-15, Article 947

2017

Volltextzugriff (PDF)

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

Cancer research (Chicago, Ill.), 2010-09, Vol.70 (18), p.7017-7026

2010

Volltextzugriff (PDF)

A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma

Scientific reports, 2022-10, Vol.12 (1), p.16538-15, Article 16538

2022

Volltextzugriff (PDF)

Fibroblast Growth Factor Receptor 1 Promotes Proliferation and Survival via Activation of the Mitogen-Activated Protein Kinase Pathway in Bladder Cancer

Cancer research (Chicago, Ill.), 2009-06, Vol.69 (11), p.4613-4620

2009

Volltextzugriff (PDF)

FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism

Molecular cancer research, 2014-07, Vol.12 (7), p.1042-1054

2014

Volltextzugriff (PDF)

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

Clinical cancer research, 2009-12, Vol.15 (24), p.7582-7592

2009

Volltextzugriff (PDF)

FGFR3 and ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma

Oncogene, 2005-08, Vol.24 (33), p.5218-5225

2005

Volltextzugriff (PDF)

A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges

Advances in Urology, 2012-01, Vol.2012 (2012), p.315-324

2012

Volltextzugriff (PDF)

Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition

Cell reports (Cambridge), 2023-10, Vol.42 (10), p.113184-113184, Article 113184

2023

Volltextzugriff (PDF)

Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes

PloS one, 2010-01, Vol.5 (1), p.e8802-e8802

2010

Volltextzugriff (PDF)

Alteration of cell-cell and cell-matrix adhesion in urothelial cells: an oncogenic mechanism for mutant FGFR3

Molecular cancer research, 2015-01, Vol.13 (1), p.138-148

2015

Volltextzugriff (PDF)

Oncogenic FGFR3 gene fusions in bladder cancer

Human molecular genetics, 2013-02, Vol.22 (4), p.795-803

2013

Volltextzugriff (PDF)

Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation

Scientific reports, 2018-05, Vol.8 (1), p.7108-13, Article 7108

2018

Volltextzugriff (PDF)

1 – 25 von 480

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(416)
Mit Volltextzugriff
(434)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(478)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(321)
Life Sciences & Biomedicine
(295)
Humans
(269)
Male
(111)
Female
(108)
Oncology
(98)
Biological And Medical Sciences
(95)
Mutation
(93)
Urinary Bladder Neoplasms - Genetics
(88)
Medical Sciences
(85)
Genetics & Heredity
(74)
Bladder Cancer
(58)
Respiratory System
(54)
Adult
(53)
Animals
(53)
Middle Aged
(52)
Tumors
(49)
Urinary Bladder Neoplasms - Pathology
(46)
Child
(45)
Nephrology. Urinary Tract Diseases
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine

Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium

The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets

Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease

Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer

Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis

Molecular Subtyping of Invasive Bladder Cancer: Time to Divide and Rule?

Distinct microRNA alterations characterize high- and low-grade bladder cancer

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer

Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer

FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms

TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma

Fibroblast Growth Factor Receptor 1 Promotes Proliferation and Survival via Activation of the Mitogen-Activated Protein Kinase Pathway in Bladder Cancer

FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

FGFR3 and ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma

A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges

Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition

Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes

Alteration of cell-cell and cell-matrix adhesion in urothelial cells: an oncogenic mechanism for mutant FGFR3

Oncogenic FGFR3 gene fusions in bladder cancer

Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation

Aktive Filter

Suchergebnisse filtern